MedTrace Logo

Evaluation of Microvolt T-Wave Alternans(MTWA) Testing for the Detection of Active Ischemia

NCT01174797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2013-05-27

No results posted yet for this study

Summary

MTWA-CAD is a feasibility study designed to evaluate Microvolt T-Wave Alternans (MTWA) testing for the purpose of detecting active ischemia in patients with known or suspected coronary artery disease (CAD). MTWA is a subtle, alternating pattern in the T wave portion of the surface electrocardiogram (ECG) that is associated with increased risk of ventricular tachyarrhythmias and sudden cardiac arrest (SCA).

Conditions

Sponsors & Collaborators

  • Cambridge Heart Inc.

    lead INDUSTRY

Principal Investigators

  • Edward J Kosinski, MD · Connecticut Clinical Research, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01174797 on ClinicalTrials.gov